Correction to “Targeting LncRNA‐Vof16: A Novel Therapeutic Strategy for Neuropathic Pain Relief”
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer-related molecular mechanisms research
X. He, D. H. Mauki, X. Zhao, et al., “Targeting LncRNA‐Vof16: A Novel Therapeutic Strategy for Neuropathic Pain Relief,” CNS Neuroscience & Therapeutics 31, no. 2 (2025): e70241.
The “Funding” and “Acknowledgments” sections have been updated to acknowledge the valuable contribution of the National Natural Science Foundation of China (Grant No. W2433199).
We apologize for this error.